Which statement best describes the risk considerations and usage pattern of benzodiazepines in anxiety treatment?

Which statement best describes the risk considerations and usage pattern of benzodiazepines in anxiety treatment?

• A. They have no dependence risk and can be used long-term safely.
• B. Risk of dependence; typically short-term use.
• C. They treat all forms of mental illness permanently.
• D. They are only used as first-line therapy for psychosis.

Answer: (B)

The main idea here is that benzodiazepines can rapidly alleviate anxiety symptoms, but they come with a real risk of dependence, so they’re generally used only for short periods. They work by enhancing the calming effects of GABA in the brain, which is why they’re so effective for acute anxiety or panic episodes and can serve as a temporary bridge while waiting for longer-term antidepressants or psychotherapy to take effect. However, with continued use, people can develop tolerance and physical dependence, and stopping them abruptly can trigger withdrawal and a rebound of anxiety. Because of these risks, clinicians typically limit use to a few weeks to a couple of months and emphasize tapering off rather than ongoing treatment. They’re not considered long-term solutions for anxiety, and they’re not appropriate for treating all mental illnesses or psychosis. Other treatments, such as SSRIs/SNRIs and cognitive-behavioral therapy, are preferred for long-term management. Use is also more cautious for those with a history of substance misuse, older adults, and when combined with alcohol or other depressants.

The main idea here is that benzodiazepines can rapidly alleviate anxiety symptoms, but they come with a real risk of dependence, so they’re generally used only for short periods. They work by enhancing the calming effects of GABA in the brain, which is why they’re so effective for acute anxiety or panic episodes and can serve as a temporary bridge while waiting for longer-term antidepressants or psychotherapy to take effect. However, with continued use, people can develop tolerance and physical dependence, and stopping them abruptly can trigger withdrawal and a rebound of anxiety. Because of these risks, clinicians typically limit use to a few weeks to a couple of months and emphasize tapering off rather than ongoing treatment. They’re not considered long-term solutions for anxiety, and they’re not appropriate for treating all mental illnesses or psychosis. Other treatments, such as SSRIs/SNRIs and cognitive-behavioral therapy, are preferred for long-term management. Use is also more cautious for those with a history of substance misuse, older adults, and when combined with alcohol or other depressants.